Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Chemistry

Liquid Chromatography-Mass Spectrometry (LCMS)

LCMS combines the physical separation technique of liquid chromatography (or HPLC) with the mass analysis technique of mass spectrometry (MS) as a detector. In MS, the compounds that elute off the column during LC are converted to the gas phase, ionized and analyzed with the MS. This power technique offers high sensitivity and selectivity to identify and quantify multiple analytes simultaneously. Except for compound identification, we use LCMS in our in vitro ADME assays, as wells as bioanalysis of pharmacokinetic studies.